CIRRHOSIS
Clinical trials for CIRRHOSIS explained in plain language.
Never miss a new study
Get alerted when new CIRRHOSIS trials appear
Sign up with your email to follow new studies for CIRRHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo tried in liver cancer patients awaiting transplant
Disease control TerminatedThis study tested two immunotherapy drugs, durvalumab and tremelimumab, in 8 people with liver cancer who were waiting for a liver transplant. The goal was to see if the drugs could safely shrink tumors and control the disease without causing organ rejection. The trial was stoppe…
Matched conditions: CIRRHOSIS
Phase: PHASE2 • Sponsor: University of Cincinnati • Aim: Disease control
Last updated May 17, 2026 04:34 UTC
-
Home monitoring for cirrhosis patients shows promise in reducing hospital returns
Disease control TerminatedThis study looked at whether using home monitoring devices and a liver care coordinator could help people with cirrhosis stay out of the hospital. It compared this approach to standard care for 120 patients. The study was stopped early, so results are limited, but the goal was to…
Matched conditions: CIRRHOSIS
Phase: EARLY_PHASE1 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Blood test holds promise for early liver cancer detection
Diagnosis TerminatedThis study looked at whether tiny bits of genetic material (extracellular RNA) found in the blood can help doctors diagnose liver cancer or other liver diseases. Researchers planned to enroll about 1,865 people with liver cancer, bile duct cancer, cirrhosis, or chronic liver dise…
Matched conditions: CIRRHOSIS
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 11, 2026 20:52 UTC
-
Liver drug trial halted early: could belapectin have prevented deadly vein bleeding?
Prevention TerminatedThis study tested a drug called belapectin to see if it could prevent the formation of enlarged veins in the throat (esophageal varices) in people with liver scarring from NASH. These veins can burst and cause life-threatening bleeding. The trial enrolled 357 adults with liver ci…
Matched conditions: CIRRHOSIS
Phase: PHASE2, PHASE3 • Sponsor: Galectin Therapeutics Inc. • Aim: Prevention
Last updated May 14, 2026 12:02 UTC
-
Can a simple frailty test predict liver transplant success?
Knowledge-focused TerminatedThis study looked at 411 adults with severe liver disease who were waiting for a liver transplant. Researchers measured frailty using simple tests like grip strength, walking speed, and weight loss to see if frailty could predict how well patients do before and after transplant. …
Matched conditions: CIRRHOSIS
Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:49 UTC